Lotus Pharm vs Intech Biopharm: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and Intech Biopharm (6461) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ Intech Biopharm

0%+2527%-100%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYIntech BiopharmYoY
Oct 2026NT$2.13 billion-22.5%NT$4,000-99.7%
Sep 2026NT$2.77 billion+128.0%NT$7.2 million+18.1%
Aug 2026NT$2.11 billion+81.7%NT$5.7 million+1,103.0%
Jul 2026NT$2.49 billion+3.9%NT$211,000-70.2%
Jun 2026NT$3.4 billion+225.5%NT$6.2 million-91.3%
May 2026NT$2.32 billion+105.8%NT$7.1 million-47.1%
Apr 2026NT$3.09 billion+19.9%NT$5.6 million+43.7%
Mar 2026NT$4.35 billion+173.6%NT$8.6 million+2,527.1%
Feb 2026NT$2.24 billion+131.5%NT$1.6 million-72.4%
Jan 2026NT$2.05 billion-5.5%NT$7.4 million+394.2%
Dec 2025NT$2.44 billion+66.9%NT$2.7 million-56.7%
Nov 2025NT$1.06 billion-0.2%NT$533,000-84.1%
Oct 2025NT$2.75 billion+46.0%NT$1.6 million+4.4%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16